The COVID‐19 Yorkshire Rehabilitation Scale (C19‐YRS): Application and psychometric analysis in a post‐COVID‐19 syndrome cohortObservational Study Published on 2021-11-052022-10-04 Journal: Journal of medical virology [Category] Fulltext, MERS, 임상, [키워드] Analysis application assumption clinical trial clinically Cohort Concordance conducted consecutive patient COVID‐19 criteria demonstrated disease Epidemiological study evaluate Evidence Health internal consistency Long COVID outcome measure Patient Patient Reported Outcome Measure (PROM) patients post‐COVID‐19 symptoms Prevalence psychometric property Psychometrics question rehabilitation relationship reliability routine clinical practice SARS CoV‐2 scale Symptoms syndrome Validity was used were used [DOI] 10.1002/jmv.27415 PMC 바로가기 [Article Type] Observational Study
487. Experience with Remdesivir for Treatment of SARS-CoV-2 in Patients with Liver CirrhosisPoster Abstracts Published on 2021-11-042022-10-29 Journal: Open Forum Infectious Diseases [Category] COVID-19, [키워드] acute respiratory syndrome Admission advanced liver disease adverse event Adverse reaction Antiviral approved cause caused Child-Pugh score Chronic Hepatitis B chronic liver disease cirrhosis clinically co-morbidities collected coronavirus coronavirus disease Course COVID-19 COVID-19 guideline demographics discharge discharged Elevation experience expired FDA hospitalized patient ICD-10 identify In-hospital in-hospital mortality Laboratory Liver cirrhosis Liver disease Mild moderate Mortality NASH National nucleotide offered outcome Patient patients patients who survived Remdesivir reported requiring supplemental oxygen Result SARS CoV-2 SARS-CoV-2 serum serum creatinine steatohepatitis therapy Treatment [DOI] 10.1093/ofid/ofab466.686 PMC 바로가기 [Article Type] Poster Abstracts
359. Clinical implications of SARS-CoV-2 PCR presumptive positive resultsPoster Abstracts Published on 2021-11-042022-10-29 Journal: Open Forum Infectious Diseases [Category] COVID-19, [키워드] acute respiratory syndrome analyzed center Cepheid clinical Clinical course clinically Combination Comorbidities Complication Concentration conditions conducted coronavirus coronavirus disease COVID-19 COVID-19 patient diagnostics discharged disease E gene Electronic health record Factors generally mild Hospitalization implication Infection information laboratory data limit of detection Mutation Oxygen requirement Patient patients PCR performed Pneumonia polymerase chain positive positive result Radiographic reported required Result retrospective Roche RT-PCR test SARS-CoV-2 SARS-CoV-2 PCR SARS-CoV-2 RT-PCR test study period symptomatic Symptoms target gene the SARS-CoV-2 transcriptase treated were recorded [DOI] 10.1093/ofid/ofab466.560 PMC 바로가기 [Article Type] Poster Abstracts
146. Intact Sense of Taste and Smell During COVID-19 Infection Is Associated with Absence of of SARS-CoV-2 Spike Protein Antibody Responses within 3 Months of Symptomatic IllnessOral Abstracts Published on 2021-11-042022-10-29 Journal: Open Forum Infectious Diseases [Category] COVID-19, [키워드] age Alpha Anosmia/ageusia antibody Antigen Asian association baseline beta coronavirus black breadth characterized clinical factors clinical phenotypes clinically Cohort collected company Control cough COVID-19 COVID-19 infection COVID-19 symptoms cross-reactivity demographics demonstrated description difference disease disease severity employee enrolled Epitopes female Fever figure group had no health system heterogeneous identify illness immune response Immunity include Intact Josh less Lilly list magnitude mild illness mild infection Month mRNA vaccination participant Patient patient population PCR-confirmed plasma sample platform Post-infection predict Prevent profile Protective Protein questionnaire Re-infection recovered patients reported response responses Result Robert SARS-CoV-1 SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 nucleocapsid SARS-CoV-2 spike protein sense sense of smell significantly Smell spike Spike protein Stephanie survivor symptom onset symptomatic Symptoms Taste tested the antibody response white [DOI] 10.1093/ofid/ofab466.146 PMC 바로가기 [Article Type] Oral Abstracts
Corticosteroids for treatment of COVID-19: effect, evidence, expectation and extentReview Published on 2021-11-042022-10-28 Journal: Beni-Suef University Journal of Basic and Applied Sciences [Category] COVID-19, [키워드] Activation age Anti-inflammatory Bacterial infections breastfeeding women can be used chemokine children clinically Combination Corticosteroid corticosteroid therapy Corticosteroids COVID-19 COVID-19 patient COVID-19 patients death Dexamethasone dosage Efficacy Evidence forms global pandemic Hospitalized Hydrocortisone hypokalemia immune cells immune response immunosuppressive effect macrophages management mechanism Medicine MERS-CoV infection Methylprednisolone moderate monocyte Mucormycosis Occurrence patients Prednisone Pregnancy Proinflammatory cytokine recorded reduce reducing Research SARS-CoV SARS-CoV-2 pandemic SARS-CoV-2 patient Side effect supplemental oxygen suppress Symptom T cells the WHO therapeutic Treatment treatment approaches WHO World Health Organization [DOI] 10.1186/s43088-021-00165-0 PMC 바로가기 [Article Type] Review
Outcomes of treatment of severe COVID-19 pneumonia with tocilizumab: a report of two cases from TunisiaTocilizumab으로 심각한 Covid-19 폐렴의 치료 결과 : 튀니지의 두 가지 사례에 대한 보고서Case Reports Published on 2021-11-022022-09-01 Journal: The Pan African Medical Journal [Category] SARS, 진단, [키워드] “cytokine storm” anti-IL6 Biological biological parameters blocking body weight Case report chest scan clinically correlated COVID-19 COVID-19 infection COVID-19 pathology COVID-19 pneumonia cytokine Cytokine storm decrease Diagnosis Evolution Health Hospitalization hypoxia IL-6 IL6 immune disorders immunomodulatory interleukin interleukin 6 interleukin-6 intravenously morbidity and mortality pandemic parameter Patient Pneumonia regulate SARS CoV SARS CoV-2 Severe case Severe COVID-19 pneumonia significantly Therapeutic approach therapy Tocilizumab tomography Treatment [DOI] 10.11604/pamj.2021.40.126.28020 PMC 바로가기 [Article Type] Case Reports
Effect of Antithrombotic Therapy on Clinical Outcomes in Outpatients With Clinically Stable Symptomatic COVID-19: The ACTIV-4B Randomized Clinical TrialRandomized Controlled Trial Published on 2021-11-022022-10-05 Journal: JAMA [Category] 임상, [키워드] 95% CI adaptive all-cause mortality Analysis anticipated Anticoagulant antiplatelet antithrombotic therapy Aspirin benefit bleeding event Cardiopulmonary clinical Clinical outcome clinically conducted COVID-19 diagnosis to randomization did not reduce dose double-blind Effect Efficacy end point Enrollment event rate Final finding Follow-up glomerular filtration rate greater groups Hospitalization Hospitalized initiated Inpatient Intervention median age median time monitoring board Myocardial infarction occurred outcome Outpatient participant Patient Placebo placebo-controlled trial Platelet prevention primary end point Prophylactic random allocation randomization Randomized randomized patient receive reduce required risk risk difference STABLE stroke symptomatic the placebo group therapeutic therapy Thromboembolism Treatment Trial trial medication venous with COVID-19 women [DOI] 10.1001/jama.2021.17272 PMC 바로가기 [Article Type] Randomized Controlled Trial
Effect of Online 1-Day Cognitive Behavioral Therapy-Based Workshops Plus Usual Care vs Usual Care Alone for Postpartum Depression: A Randomized Clinical TrialRandomized Controlled Trial Published on 2021-11-012022-10-05 Journal: JAMA Psychiatry [Category] Fulltext, MERS, 임상, [키워드] 95% CI added addition Affect age Anxiety assigned baseline Behavior bonding Canada clinical clinically cognitive control group COVID-19 pandemic determine Edinburgh Effect effective eligible exhibiting form GAD-7 Generalized higher odd IMPROVE improvement Infant Odds ratio offspring Older outcome participant positive Postpartum Postpartum depression preference Primary outcome provide randomized clinical trial Randomly receive recruited reduced reducing reductions in Registered reported risk scale secondary significant decrease Support therapy Treatment treatment as usual Virtual care women workshop [DOI] 10.1001/jamapsychiatry.2021.2488 PMC 바로가기 [Article Type] Randomized Controlled Trial
Assessment of antiphospholipid antibodies and calprotectin as biomarkers for discriminating mild from severe COVID-19경증에서 중증 COVID-19를 구별하기 위한 바이오마커로서의 항인지질 항체 및 칼프로텍틴의 평가Article Published on 2021-11-012022-09-11 Journal: Journal of Clinical Laboratory Analysis [Category] MERS, SARS, 바이오마커, 진단, 치료기술, [키워드] acute respiratory distress acute respiratory distress syndrome antibodies antibody anticardiolipin antibodies anticardiolipin antibody antiphospholipid antibodies assessment association Biomarker C-reactive protein C-reactive protein (CRP calprotectin CD4 clinically coronavirus coronavirus disease correlation COVID-19 COVID-19 patient COVID-19 patients CRP CRP level CRP levels detectable Detection limit elevated ELISA enzyme enzyme-linked immunosorbent enzyme-linked immunosorbent assay evaluated ferritin groups healthy control healthy controls help highest Hospitalization hospitalized COVID-19 patient hospitalized COVID-19 patients IgM immunoassay IMPROVE Inflammatory laboratory parameter lymphocyte Lymphocyte count management Mild moderate multiplex negative correlation neutrophil Neutrophil-to-lymphocyte ratio no significant differences not differ outcome oxygenation status parameter pathway peak levels Prevalence procalcitonin proportion respiratory distress Respiratory distress syndrome sera severe COVID-19 severe group severity significant differences significantly significantly higher syndrome T cells two group two groups were measured [DOI] 10.1002/jcla.24004 PMC 바로가기 [Article Type] Article
Public perception of NHS general practice during the first six months of the COVID-19 pandemic in EnglandBrief Report Published on 2021-11-012022-10-31 Journal: F1000Research [Category] COVID-19, MERS, SARS, [키워드] assessment change clinically conducted Contact coronavirus COVID-19 COVID-19 pandemic delivery model England experience face-to-face consultation face-to-face contact General practice healthcare help measure mitigate MOST NHS Patient patient communication Patient experience patients with COVID-19 Perspective preference Public receiving reduce reduced remote reported required SARS-CoV-2 transmission spread of COVID-19 survey was reduced while [DOI] 10.12688/f1000research.52392.2 PMC 바로가기 [Article Type] Brief Report